We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




P-O-C Test Detects IgG Antibody in Serodiagnosis of Human Trichinellosis

By LabMedica International staff writers
Posted on 23 Nov 2021
Print article
Image: Histopathology of encysted larvae of Trichinella sp. in muscle tissue (Photo courtesy of Centers for Disease Control and Prevention)
Image: Histopathology of encysted larvae of Trichinella sp. in muscle tissue (Photo courtesy of Centers for Disease Control and Prevention)
Trichinellosis is one of the most critical food-borne parasitic zoonoses worldwide. Humans acquire trichinellosis by ingesting raw or undercooked meats containing the infective Trichinella larvae. Adult Trichinella spp. reside in the intestinal tract of the vertebrate host; larvae can be found encapsulated in muscle tissue.

There are two classes of methods for the detection of Trichinella infection in humans or animals. Methods such as trichinoscopy (compression method) and the artificial digestion method directly test for the presence of parasites in tissues or digests. The other class of methods indirectly demonstrates infection by detecting specific antibodies using serological methods.

Medical Parasitologists at the Khon Kaen University (Khon Kaen, Thailand) and their colleagues developed an immunochromatographic test (ICT) kit to diagnose trichinellosis by detecting IgG antibodies in sera of infected humans. Human serum samples were used for the evaluation of the diagnostic properties of the test. The samples were divided into three groups: 1) the negative control group (n = 30) comprised samples from healthy adult volunteers who were free (based on stool examination using the formalin ethyl-acetate concentration technique (FECT); 2) the trichinellosis group (n = 31), which comprised samples from outbreak cases in northern Thailand) and 116 serum samples from patients with parasitic infections other than trichinellosis.

The team used somatic extract from Trichinella spiralis larvae was used as the antigen for the immunochromatographic test (ICT) kit development. Diagnostic efficacy was evaluated using human serum samples from proven trichinellosis patients, healthy persons, and those with other parasitic infections. The ICT device for diagnosing human trichinellosis was designed based on the specificity of antibodies against T. spiralis larval somatic antigens.

The investigators reported that all 31 trichinellosis serum samples yielded positive results using a cutoff value of 1. In contrast, none of the 30 healthy control sera showed positive results. Cross-reactivity was observed in serum samples from cases of gnathostomiasis (1 of 10), cysticercosis (1 of 10), paragonimiasis (3 of 10), and fascioliasis (6 of 10). The diagnostic values of the trichinellosis (Ts)-ICT were calculated with the results from all serum samples. The diagnostic sensitivity, specificity, positive and negative predictive values and accuracy of the ICT kit were 100.0%, 92.5%, 73.8%, 100.0%, and 93.8%, respectively.

The authors concluded that the ICT diagnostic kit can be used as a testing tool for human trichinellosis. This test should permit rapid detection of infection to enable prompt anthelminthic treatment. It can also be used for retrospective diagnoses and field surveys based at laboratories where sophisticated equipment is lacking. The study was published in the October, 2021 issue of International Journal of Infectious Diseases.

Related Links:
Khon Kaen University

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Ultra-Low Temperature Freezer
iUF118-GX

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.